Adrian Roth

4.2k total citations · 1 hit paper
65 papers, 2.7k citations indexed

About

Adrian Roth is a scholar working on Molecular Biology, Biomedical Engineering and Pharmacology. According to data from OpenAlex, Adrian Roth has authored 65 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 22 papers in Biomedical Engineering and 14 papers in Pharmacology. Recurrent topics in Adrian Roth's work include 3D Printing in Biomedical Research (21 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Liver physiology and pathology (8 papers). Adrian Roth is often cited by papers focused on 3D Printing in Biomedical Research (21 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Liver physiology and pathology (8 papers). Adrian Roth collaborates with scholars based in Switzerland, United States and Germany. Adrian Roth's co-authors include Thomas P. Singer, Laura Suter‐Dick, Franziska Boess, Deborah G. Nguyen, Candace Crogan‐Grundy, Urs Meyer, Sharon C. Presnell, Justin B. Robbins, Juergen Funk and Cornelia Hertel and has published in prestigious journals such as Science, Nature Communications and Bioinformatics.

In The Last Decade

Adrian Roth

63 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The evolving role of investigative toxicology in the pharmaceutical industry

2023 132 citations Mario Beilmann, Adrian Roth et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adrian Roth Switzerland	29	1.2k	962	396	353	350	65	2.7k
Laura Suter‐Dick Switzerland	27	661 0.6×	1.1k 1.2×	352 0.9×	292 0.8×	285 0.8×	70	2.4k
Souren Mkrtchian Sweden	30	286 0.2×	1.1k 1.1×	791 2.0×	512 1.5×	361 1.0×	62	2.9k
B. Kevin Park United Kingdom	25	415 0.3×	744 0.8×	749 1.9×	378 1.1×	813 2.3×	36	2.4k
Lorna Ewart United Kingdom	23	882 0.7×	449 0.5×	92 0.2×	166 0.5×	116 0.3×	64	1.8k
Franziska Boess Switzerland	19	227 0.2×	623 0.6×	343 0.9×	175 0.5×	286 0.8×	31	1.4k
Tao Wu China	34	196 0.2×	1.3k 1.3×	151 0.4×	285 0.8×	118 0.3×	110	3.0k
Núria Jiménez Spain	24	123 0.1×	661 0.7×	385 1.0×	159 0.5×	292 0.8×	33	1.7k
Evita van de Steeg Netherlands	29	220 0.2×	619 0.6×	469 1.2×	1.2k 3.4×	90 0.3×	59	2.5k
Yan Cao China	34	160 0.1×	2.1k 2.1×	360 0.9×	435 1.2×	85 0.2×	172	3.5k
Tomomi Furihata Japan	28	108 0.1×	748 0.8×	270 0.7×	485 1.4×	127 0.4×	98	1.9k

Countries citing papers authored by Adrian Roth

Since Specialization

Citations

This map shows the geographic impact of Adrian Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrian Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrian Roth more than expected).

Fields of papers citing papers by Adrian Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrian Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrian Roth. The network helps show where Adrian Roth may publish in the future.

Co-authorship network of co-authors of Adrian Roth

This figure shows the co-authorship network connecting the top 25 collaborators of Adrian Roth. A scholar is included among the top collaborators of Adrian Roth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrian Roth. Adrian Roth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brusilovsky, Michael, Elizabeth Buck, W. Clark Bacon, et al.. (2025). Autologous Organoid‐T Cell Co‐Culture Platform for Modeling of Immune‐Mediated Drug‐Induced Liver Injury. Advanced Science. 12(43). e08584–e08584.

Stirn, Martina, et al.. (2025). iPSC-hepatocyte organoids as a novel platform to predict AAV gene therapy efficacy. Molecular Therapy — Methods & Clinical Development. 33(2). 101467–101467. 1 indexed citations

Gjorevski, Nikolce, Régine Gérard, Lauriane Cabon, et al.. (2020). Neutrophilic infiltration in organ-on-a-chip model of tissue inflammation. Lab on a Chip. 20(18). 3365–3374. 62 indexed citations

Nudischer, Ramona, et al.. (2020). Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity. PLoS ONE. 15(7). e0235745–e0235745. 13 indexed citations

McAleer, Christopher W., Christopher J. Long, Daniel Elbrecht, et al.. (2019). Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics. Science Translational Medicine. 11(497). 141 indexed citations

Trietsch, Sebastiaan J., Elena Naumovska, Dorota Kurek, et al.. (2017). Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. Nature Communications. 8(1). 262–262. 223 indexed citations

Boess, Franziska, Barbara Lenz, Juergen Funk, et al.. (2017). Use of early phenotypic in vivo markers to assess human relevance of an unusual rodent non-genotoxic carcinogen in vitro. Toxicology. 379. 48–61. 2 indexed citations

Moisan, Annie, Marcel Gubler, Jitao David Zhang, et al.. (2016). Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling. Molecular Therapy — Nucleic Acids. 6. 89–105. 24 indexed citations

Sewing, Sabine, Franziska Boess, Annie Moisan, et al.. (2016). Establishment of a Predictive In Vitro Assay for Assessment of the Hepatotoxic Potential of Oligonucleotide Drugs. PLoS ONE. 11(7). e0159431–e0159431. 28 indexed citations

10.

Berger, Benjamin, Massimiliano Donzelli, Franziska Boess, et al.. (2016). Comparison of Liver Cell Models Using the Basel Phenotyping Cocktail. Frontiers in Pharmacology. 7. 443–443. 68 indexed citations

11.

Meille, Christophe, Stefan Kustermann, Isabelle Walter, et al.. (2015). Model-based assessment of erlotinib effect in vitro measured by real-time cell analysis. Journal of Pharmacokinetics and Pharmacodynamics. 42(3). 275–285. 2 indexed citations

12.

Suter‐Dick, Laura, Paula M. Alves, Bas J. Blaauboer, et al.. (2015). Stem Cell-Derived Systems in Toxicology Assessment. Stem Cells and Development. 24(11). 1284–1296. 43 indexed citations

13.

Roth, Adrian & Thomas P. Singer. (2014). The application of 3D cell models to support drug safety assessment: Opportunities & challenges. Advanced Drug Delivery Reviews. 69-70. 179–189. 73 indexed citations

14.

Buneß, Andreas, Adrian Roth, Annika Herrmann, et al.. (2014). Identification of Metabolites, Clinical Chemistry Markers and Transcripts Associated with Hepatotoxicity. PLoS ONE. 9(5). e97249–e97249. 24 indexed citations

15.

DesRochers, Teresa M., Laura Suter‐Dick, Adrian Roth, & David L. Kaplan. (2013). Bioengineered 3D Human Kidney Tissue, a Platform for the Determination of Nephrotoxicity. PLoS ONE. 8(3). e59219–e59219. 90 indexed citations

16.

Roth, Adrian, et al.. (2013). Data mining reveals a network of early-response genes as a consensus signature of drug-induced in vitro and in vivo toxicity. The Pharmacogenomics Journal. 14(3). 208–216. 62 indexed citations

17.

Režen, Tadeja, Peter Juvan, Klementina Fon Tacer, et al.. (2008). The Sterolgene v0 cDNA microarray: a systemic approach to studies of cholesterol homeostasis and drug metabolism. BMC Genomics. 9(1). 76–76. 16 indexed citations

18.

Scarsi, Marco, Michael Podvinec, Adrian Roth, et al.. (2006). Sulfonylureas and Glinides Exhibit Peroxisome Proliferator-Activated Receptor γ Activity: A Combined Virtual Screening and Biological Assay Approach. Molecular Pharmacology. 71(2). 398–406. 42 indexed citations

19.

Gnerre, Carmela, Gertrud U. Schuster, Adrian Roth, et al.. (2005). LXR deficiency and cholesterol feeding affect the expression and phenobarbital-mediated induction of cytochromes P450 in mouse liver. Journal of Lipid Research. 46(8). 1633–1642. 25 indexed citations

20.

Roth, Adrian, Ramanjit Gill, & Ulrich Certa. (2003). Temporal and spatial gene expression patterns after experimental stroke in a rat model and characterization of PC4, a potential regulator of transcription. Molecular and Cellular Neuroscience. 22(3). 353–364. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact